News | June 11, 2026
Glenmark launches Winlevi across key European markets
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
Programme aims to strengthen fertility care expertise through advanced clinical training, mentorship and hands-on experience in reproductive medicine
The Prayagraj lab is designed to handle both routine and specialised testing
Digital platform aims to expand access to palliative care through teleconsultations, training, community engagement and global knowledge-sharing
Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
